Source: Annual Congress 2003 - Asthma and COPD: from cell regulation to histopathology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, N. M. Siafakas (Heraklion, Greece). Increased heme oxygenase-1 and -2 expression in severe COPD exacerbations. Eur Respir J 2003; 22: Suppl. 45, 3429

Member's Comments

No comment yet.

Related content which might interest you: Impaired haem oxygenase-1 expression in sputum macrophages of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Haem oxygenase-1 expression is diminished in alveolar macrophages of patients with COPD Source: Eur Respir J 2004; 23: 652-653 Year: 2004 Serum haem oxygenase-1 as marker of lung function in patients with chronic silicosis Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009 Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients Source: Eur Respir J 2003; 21: 971-976 Year: 2003 Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 31: 1030-1036 Year: 2008 Different expression of heme oxygenase-1 in alveolar macrophages in idiopathic interstitial pneumonia Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007 Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 c-Fos overexpression induces resistance to hyperoxia by the upregulation of heme oxygenase-1 Source: Eur Respir J 2004; 24: Suppl. 48, 106s Year: 2004 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Increased small intestinal permeability during severe acute exacerbations of COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Sputum VEGF level increases with treatment of COPD acute exacerbation Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009